The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

February 9, 2016 – Proove Release: Proove Presents Data at Leading Scientific Meeting

by | February 12, 2018 | In the News | 0 Comments

(PRWEB) February 19, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, presented findings on the link between genetics and pain at the American Academy of Pain Management's (AAPM) 32nd Annual Meeting. As the only company...
Read More

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

by | February 12, 2018 | Press Releases | 0 Comments

New Peer-Reviewed Prospective Study Shows that Proove Opioid Risk® Profile Results in Better Pain Management Decisions Providing a 50% Reduction in Pain IRVINE, Calif., Aug. 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces yet another new...
Read More

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

by | February 12, 2018 | In the News | 0 Comments

The new Proove Non-Opioid Pain Medication Response profile evaluates genetic factors to predict a patient’s response to non opioids before prescribing Irvine, CA (PRWEB) - Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to...
Read More

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...
Read More

March 30, 2016 – Proove Release: Proove Expands Sales Force

by | February 12, 2018 | Press Releases | 0 Comments

IRVINE, CA (PRWEB) MARCH 30, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized...
Read More

April 25, 2017 – Proove Release: Milestone of the World’s Largest Biobank and Big Data Set in Chronic Pain –

by | February 12, 2018 | Press Releases | 0 Comments

Proove® Announces Huge Milestone for its Proove Nexus™ Big Data Platform Commemorating National DNA Day IRVINE, Calif., April 25, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its Proove Nexus™ platform is the World's Largest DNA Pain Biobank and Big...
Read More

May 2, 2017 – Proove Release: Proove CEO to Speak at 5 th Annual Medical Device Forum

by | February 12, 2018 | Press Releases | 0 Comments

Award-Winning Entrepreneur Brian Meshkin will speak at the 10X Medical Device Conference in San Diego IRVINE, Calif., May 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and Chief Executive Officer, Brian Meshkin, will speak at the...
Read More

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...
Read More

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...
Read More

May 4, 2016 – Proove Release: Proove Announces Collaboration with McGill University

by | February 12, 2018 | In the News | 0 Comments

New Agreement Creates Collaborative Framework for Commercializing Laboratory Research to Help Pain Patients Irvine, CA (PRWEB) May 04, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce a strategic...
Read More

Video’s

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Get Instant Access to Updates to The Truth about Proove Bio